-+ 0.00%
-+ 0.00%
-+ 0.00%

CVRX ANNOUNCES FIRST PATIENT ENROLLMENT IN BENEFIT-HF, A LANDMARK HEART FAILURE TRIAL EVALUATING BAROSTIM IN SIGNIFICANTLY EXPANDED POPULATION

Reuters·05/04/2026 20:30:00

Please log in to view news